Roseburia intestinalis sensitizes colorectal cancer to radiotherapy through the butyrate/OR51E1/RALB axis
Cell Reports · 2024-07 · 43 (7) · 114407
DOI: 10.1016/j.celrep.2024.114407 ↗Kurz gefasst
Korrektur in der Zeitschrift Cell Reports, 2024-07. Verfasst von Jiali Dong und 12 weiteren Autor:innen. Die Arbeit wurde bisher 17-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Dong, J., Wang, B., Xiao, Y., Liu, J., Wang, Q., Xiao, H., Jin, Y., Liu, Z., Chen, Z., Li, Y., Fan, S., Li, Y., & Cui, M. (2024). Roseburia intestinalis sensitizes colorectal cancer to radiotherapy through the butyrate/OR51E1/RALB axis. Cell Reports, 43(7), 114407. https://doi.org/10.1016/j.celrep.2024.114407
Vancouver
Dong J, Wang B, Xiao Y, Liu J, Wang Q, Xiao H, et al. Roseburia intestinalis sensitizes colorectal cancer to radiotherapy through the butyrate/OR51E1/RALB axis. Cell Reports. 2024;43(7):114407. doi:10.1016/j.celrep.2024.114407
BibTeX
@article{Dong2024,
author = {Dong, Jiali and Wang, Bin and Xiao, Yunong and Liu, Jia and Wang, Qi and Xiao, Huiwen and Jin, Yuxiao and Liu, Zhihong and Chen, Zhiyuan and Li, Yiliang and Fan, Saijun and Li, Yuan and Cui, Ming},
title = {Roseburia intestinalis sensitizes colorectal cancer to radiotherapy through the butyrate/OR51E1/RALB axis},
journal = {Cell Reports},
year = {2024},
volume = {43},
number = {7},
pages = {114407},
doi = {10.1016/j.celrep.2024.114407}
}
EUVIMED